Dialysis is a treatment for kidney failure that filters blood to eliminate unwanted toxins, waste products and excess fluids.
Latest ISN Journal Editorial Selections
Kidney International: Results From Part A of the Multi-center, Double-blind, Randomized, Placebo-controlled Nefigard Trial, Which Evaluated Targeted-release Formulation of Budesonide for the Treatment of Primary Immunoglobulin A Nephropathy To verify the findings of the 2b NEFIGAN trial, the phase 3 NefigArd trial tested the efficacy and safety of nine months of treatment with Nefecon® versus placebo...